📰 Michael Lenardo News
Michael Lenardo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Lenardo. Real-time updates on events, politics, business and more.
March 28, 2024
/PRNewswire/ -- Calico Life Sciences LLC (Calico), a biotechnology organization focused on the biology of aging and age-related diseases, and founded by...
August 22, 2023
The FDA has approved Veopoz (pozelimab-bbfg) for the treatment of CD55-deficient protein-losing enteropathy, also known as CHAPLE disease.
August 21, 2023
TARRYTOWN - Regeneron Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration has approved Veopoz for the treatment of adult and pediatric patients 1 year of age and older with...
August 18, 2023
18.08.2023 - CHAPLE is an ultra-rare hereditary disease that can cause potentially life-threatening gastrointestinal and cardiovascular symptoms Approval represents 10th FDA-approved medicine invented by Regeneron With the approval of Veopoz, the ...
August 18, 2023
CHAPLE is an ultra-rare hereditary disease that can cause potentially life-threatening gastrointestinal and cardiovascular symptoms Approval represents 10th FDA-approved medicine invented by...
August 18, 2023
The FDA approval of pozelimab (Veopoz) makes it the first and only treatment indicated for children and adults with CHAPLE disease.
August 18, 2023
Pozelimab reduced hospitalizations, albumin transfusions in CHAPLE disease patients